Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3683201 | 0.79 | HTR2A (0.33) | — | |
| SCHEMBL3676744 | 0.79 | KDM4E (0.30) | — | |
| SCHEMBL7647636 | 0.77 | PNMT (0.48) | HTR6 | |
| SCHEMBL7613461 | 0.76 | PNMT (0.47) | HTR6 | |
| SCHEMBL7604393 | 0.76 | PNMT (0.47) | HTR6 | |
| Hydrochloric Acid SCHEMBL5346729 | 0.75 | PNMT (0.46) | HTR6 | |
| Hydrochloric Acid SCHEMBL5357721 | 0.75 | PNMT (0.46) | HTR6 | |
| SCHEMBL5954199 | 0.73 | HTR2A (0.36) | — | |
| SCHEMBL13905661 | 0.71 | KDM4E (0.33) | — | |
| SCHEMBL1319401 | 0.71 | KDM4E (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569532-B2 | Catalysts | BOREALIS TECHNOLOGY OY (FI) | 2013-10-29 | — | — | US | disclosed |
| US-20120252993-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2012-10-04 | — | — | US | disclosed |
| US-20100305286-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120252993-A1 | CATALYSTS | CYP4F11, COXFA4, CYP2F1 | HTR6 4500/4885SIGMAR1 648/4885 |
| US-20100305286-A1 | CATALYSTS | H1-2, CCNL2, H1-3 | HTR6 3352/4885SIGMAR1 84/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.